$SPRO Spero Therapeutics, Inc. Insider Trading Week 26/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Spero Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Spero Therapeutics, Inc. in week 26/2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Larkin Cristina | Chief Operating Off ... | Option Exercise | M | 5.90 | 4,000 | 23,600 | 20,434 | |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Larkin Cristina | Chief Operating Off ... | Sell | S | 17.50 | 4,000 | 70,000 | 1,500 | 5.5 K to 1.5 K (-72.73 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Larkin Cristina | Chief Operating Off ... | Buy | M | 5.90 | 4,000 | 23,600 | 5,500 | 1.5 K to 5.5 K (+266.67 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Sendek Joel | Chief Financial Off ... | Option Exercise | M | 5.90 | 2,000 | 11,800 | 165,833 | |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Sendek Joel | Chief Financial Off ... | Sell | S | 17.50 | 2,000 | 35,000 | 15,181 | 17.2 K to 15.2 K (-11.64 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Sendek Joel | Chief Financial Off ... | Buy | M | 5.90 | 2,000 | 11,800 | 17,181 | 15.2 K to 17.2 K (+13.17 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Option Exercise | M | 5.90 | 1,600 | 9,440 | 118,888 | |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Option Exercise | M | 5.90 | 3,076 | 18,148 | 120,488 | |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.92 | 200 | 3,584 | 65,817 | 66 K to 65.8 K (-0.30 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.90 | 200 | 3,580 | 66,017 | 66.2 K to 66 K (-0.30 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.71 | 100 | 1,771 | 66,217 | 66.3 K to 66.2 K (-0.15 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.62 | 100 | 1,762 | 66,317 | 66.4 K to 66.3 K (-0.15 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.58 | 400 | 7,032 | 66,417 | 66.8 K to 66.4 K (-0.60 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.55 | 100 | 1,755 | 66,817 | 66.9 K to 66.8 K (-0.15 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.50 | 500 | 8,750 | 66,917 | 67.4 K to 66.9 K (-0.74 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Buy | M | 5.90 | 1,600 | 9,440 | 67,417 | 65.8 K to 67.4 K (+2.43 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.62 | 3,076 | 54,204 | 65,817 | 68.9 K to 65.8 K (-4.46 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Buy | M | 5.90 | 3,076 | 18,148 | 68,893 | 65.8 K to 68.9 K (+4.67 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Larkin Cristina | Chief Operating Off ... | Option Exercise | M | 5.90 | 4,000 | 23,600 | 20,434 | |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Larkin Cristina | Chief Operating Off ... | Sell | S | 17.50 | 4,000 | 70,000 | 1,500 | 5.5 K to 1.5 K (-72.73 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Larkin Cristina | Chief Operating Off ... | Buy | M | 5.90 | 4,000 | 23,600 | 5,500 | 1.5 K to 5.5 K (+266.67 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Sendek Joel | Chief Financial Off ... | Option Exercise | M | 5.90 | 2,000 | 11,800 | 165,833 | |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Sendek Joel | Chief Financial Off ... | Sell | S | 17.50 | 2,000 | 35,000 | 15,181 | 17.2 K to 15.2 K (-11.64 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Sendek Joel | Chief Financial Off ... | Buy | M | 5.90 | 2,000 | 11,800 | 17,181 | 15.2 K to 17.2 K (+13.17 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Option Exercise | M | 5.90 | 1,600 | 9,440 | 118,888 | |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Option Exercise | M | 5.90 | 3,076 | 18,148 | 120,488 | |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.92 | 200 | 3,584 | 65,817 | 66 K to 65.8 K (-0.30 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.90 | 200 | 3,580 | 66,017 | 66.2 K to 66 K (-0.30 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.71 | 100 | 1,771 | 66,217 | 66.3 K to 66.2 K (-0.15 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.62 | 100 | 1,762 | 66,317 | 66.4 K to 66.3 K (-0.15 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.58 | 400 | 7,032 | 66,417 | 66.8 K to 66.4 K (-0.60 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.55 | 100 | 1,755 | 66,817 | 66.9 K to 66.8 K (-0.15 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.50 | 500 | 8,750 | 66,917 | 67.4 K to 66.9 K (-0.74 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Buy | M | 5.90 | 1,600 | 9,440 | 67,417 | 65.8 K to 67.4 K (+2.43 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Sell | S | 17.62 | 3,076 | 54,204 | 65,817 | 68.9 K to 65.8 K (-4.46 %) |
| Jul 06 2018 | SPRO | Spero Therapeutics ... | Mahadevia Ankit | See Remarks | Buy | M | 5.90 | 3,076 | 18,148 | 68,893 | 65.8 K to 68.9 K (+4.67 %) |